Top Markets
Coin of the day
Golden Biotechnology Corporation Golden Biotechnology Corporation

Golden Biotechnology Corporation

4132
株式のランク #29677
Golden Biotechnology Corporation, founded in 2002 and based in New Taipei City,... Golden Biotechnology Corporation, founded in 2002 and based in New Taipei City, Taiwan, is engaged in both pharmaceutical drug discovery and the production of health-enhancing dietary supplements. The company operates internationally, serving markets in Taiwan, the United States, Japan, China, Korea, and Singapore. Its varied product line includes several health supplements: Liverty, formulated to support liver function and help alleviate fatigue. Rasle, which serves as an adjunctive therapy for autoimmune conditions. ZSAINO, a nutritional product designed to aid recovery from illness and boost general well-being. UMOOZE, a specialized herbal blend targeting optimal health for men. Furthermore, Golden Biotechnology is developing Antroquinonol, an anticancer molecule. This compound is currently utilized in the treatment of severe conditions such as pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, in addition to addressing hypercholesterolemia and hyperlipidemia.
株価
$0.11034263
最終同期: 2026-04-09
時価総額
$20.11M
変化(1日)
-31.83%
変化(1年)
-73.09%
TW
取引 Golden Biotechnology Corporation (4132)

カテゴリー

Golden Biotechnology Corporation(4132)の株価履歴
終値の最高値: $0.13 (2026-04-01)

終値の最安値: $0.82 (2012-06-01)
Golden Biotechnology Corporation の株価履歴(2012 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -34.43%
2025 52.97%
2024 -61.33%
2023 -40.03%
2022 -43.02%
2021 127.12%
2020 48.00%
2019 20.35%
2018 -31.64%
2017 -10.81%
2016 -8.54%
2015 52.98%
2014 0.33%
2013 24.21%
2012 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$171.67 -
DE
$163.21 26.26%
DE
$37.64 23.14%
JP
$223.44 33.45%
CH
$20.96 12.20%
IN